Oragenics Inc
OGEN
Revenue
0.00
▼-7.47k▼-100.00%
3 Months ChangeAssets
2.71M
▼-824.25k▼-23.32%
3 Months ChangeLiabilities
1.38M
▲474.62k▲52.23%
3 Months ChangeFree Cash Flow
-5.72M
▼-5.72M-∞%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-18
Form 8-K
ID: 0001493152-24-041500
2024-10-16
Form 8-K
ID: 0001493152-24-041255
2024-10-15
Form 8-K
ID: 0001493152-24-040974
2024-10-09
Form 8-K
ID: 0001493152-24-040523
2024-09-20
Form 8-K
ID: 0001493152-24-037602
2024-09-05
Form 8-K
ID: 0001493152-24-035166
2024-08-21
Form 8-K
ID: 0001493152-24-033383
2024-08-16
Form 8-K
ID: 0001493152-24-032831
2024-08-14
Form 8-K
ID: 0001493152-24-031898
2024-08-12
Form 8-K
ID: 0001493152-24-031163